KMT2A and acute lymphoblastic leukemia: Despite this strong association with an exceedingly poor prognosis, a recent study by Emerenciano et al. suggested that RAS mutations in MLL-rearranged infant ALL may not act as driver mutations and are not required for disease progression, but rather act only at disease onset [4].